Eliot Finkel Investment Counsel’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-54,055
| Closed | -$4.32M | – | 32 |
|
|
2024
Q4 | $4.32M | Sell |
54,055
-55
| -0.1% | -$4.76K | 2.75% | 17 |
|
|
2024
Q3 | $4.87M | Sell |
54,110
-1,160
| -2% | -$97.6K | 2.99% | 17 |
|
|
2024
Q2 | $4.35M | Sell |
55,270
-60
| -0.1% | -$4.92K | 2.86% | 18 |
|
|
2024
Q1 | $4.82M | Buy |
55,330
+11,273
| +26% | +$962K | 3.12% | 18 |
|
|
2023
Q4 | $3.63M | Sell |
44,057
-2,540
| -5% | -$194K | 2.44% | 18 |
|
|
2023
Q3 | $3.65M | Buy |
46,597
+560
| +1% | +$46.9K | 2.45% | 18 |
|
|
2023
Q2 | $4.06M | Sell |
46,037
-7,085
| -13% | -$610K | 2.57% | 17 |
|
|
2023
Q1 | $4.28M | Sell |
53,122
-60
| -0.1% | -$4.89K | 2.73% | 18 |
|
|
2022
Q4 | $4.13M | Buy |
53,182
+8,860
| +20% | +$718K | 2.62% | 20 |
|
|
2022
Q3 | $3.58M | Buy |
44,322
+800
| +2% | +$71.9K | 2.65% | 18 |
|
|
2022
Q2 | $3.91M | Hold |
43,522
| – | – | 2.83% | 17 |
|
|
2022
Q1 | $4.83M | Buy |
43,522
+1,995
| +5% | +$211K | 2.85% | 18 |
|
|
2021
Q4 | $4.3M | Sell |
41,527
-430
| -1% | -$49.8K | 2.51% | 19 |
|
|
2021
Q3 | $5.26M | Hold |
41,957
| – | – | 3.37% | 15 |
|
|
2021
Q2 | $5.21M | Sell |
41,957
-40
| -0.1% | -$5.02K | 3.35% | 14 |
|
|
2021
Q1 | $4.96M | Sell |
41,997
-50
| -0.1% | -$5.86K | 3.19% | 16 |
|
|
2020
Q4 | $4.92M | Sell |
42,047
-160
| -0.4% | -$17.6K | 3.72% | 14 |
|
|
2020
Q3 | $4.39M | Sell |
42,207
-30
| -0.1% | -$3.01K | 3.91% | 12 |
|
|
2020
Q2 | $3.87M | Sell |
42,237
-1,400
| -3% | -$134K | 3.83% | 13 |
|
|
2020
Q1 | $3.94M | Sell |
43,637
-100
| -0.2% | -$10.6K | 4.29% | 10 |
|
|
2019
Q4 | $4.96M | Sell |
43,737
-440
| -1% | -$48.3K | 3.21% | 16 |
|
|
2019
Q3 | $4.8M | Sell |
44,177
-600
| -1% | -$62.6K | 3.43% | 15 |
|
|
2019
Q2 | $4.36M | Buy |
44,777
+450
| +1% | +$41.1K | 2.8% | 18 |
|
|
2019
Q1 | $4.04M | Buy |
44,327
+580
| +1% | +$51.9K | 2.68% | 18 |
|
|
2018
Q4 | $3.98M | Sell |
43,747
-500
| -1% | -$46.7K | 2.91% | 16 |
|
|
2018
Q3 | $4.35M | Hold |
44,247
| – | – | 2.77% | 18 |
|
|
2018
Q2 | $3.79M | Sell |
44,247
-370
| -0.8% | -$30.9K | 2.56% | 19 |
|
|
2018
Q1 | $3.58M | Buy |
44,617
+18,060
| +68% | +$1.49M | 2.52% | 20 |
|
|
2017
Q4 | $2.14M | Hold |
26,557
| – | – | 1.41% | 30 |
|
|
2017
Q3 | $2.06M | Hold |
26,557
| – | – | 1.47% | 29 |
|
|
2017
Q2 | $2.36M | Sell |
26,557
-200
| -0.7% | -$16.9K | 1.73% | 29 |
|
|
2017
Q1 | $2.16M | Hold |
26,757
| – | – | 1.66% | 28 |
|
|
2016
Q4 | $1.91M | Sell |
26,757
-12,000
| -31% | -$943K | 1.62% | 26 |
|
|
2016
Q3 | $3.35M | Hold |
38,757
| – | – | 3.01% | 20 |
|
|
2016
Q2 | $3.36M | Sell |
38,757
-3,050
| -7% | -$247K | 3% | 18 |
|
|
2016
Q1 | $3.14M | Sell |
41,807
-500
| -1% | -$37.7K | 2.85% | 19 |
|
|
2015
Q4 | $3.25M | Buy |
+42,307
| New | +$3.18M | 3.13% | 16 |
|
Other funds holding MDT
Eliot Finkel Investment Counsel's MDT Position: Q1 2025 in Review
Eliot Finkel Investment Counsel sold out of Medtronic (MDT) in Q1 2025, closing a stake of 54,055 shares — an estimated $4.32M sold.
Eliot Finkel Investment Counsel first reported a position in MDT in Q4 2015 and held it in 37 quarters. The position peaked at $5.26M in Q3 2021. 2,171 funds tracked by Wall St. Rank hold MDT as of Q1 2025.
- Eliot Finkel Investment Counsel reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
- Eliot Finkel Investment Counsel sold 54,055 Medtronic shares in Q1 2025, an estimated $4.32M.
- Eliot Finkel Investment Counsel first reported a position in Medtronic in Q4 2015 and held it in 37 quarters.
- Eliot Finkel Investment Counsel's Medtronic position peaked at $5.26M in Q3 2021.
- 2,171 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.
Based on Eliot Finkel Investment Counsel's 13F filing for Q1 2025, filed 9 May 2025.